Why do intelligent people, many with advanced degrees and business experience, fail to get the purpose and benefits of IP rights? Where’s the disconnect” One
Tag: drug discovery
2025-2030 Patent “Cliff” will Impact Some Pharma Companies More Than Others
The cost to develop new drugs and vaccines is growing and the success rate may be slowing. Likelihood of approval for new FDA Phase I
Cancer Patents may be an Indication of Future Company Performance and Research Efficiency
Novartis and Roche enjoy pharma-industry leading 2024 revenues. They also lead in total international patent volume. But Roche, with more oncology-specific patents for cancer treatment
